-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JxTf7mKUlJzKkNwgrVhWWHIsGj8x3W7Q/Ph7+lHUU6HCIqUIAjj43RWQngblJygR lfNTNbKeQOMIQHYt/Zvzrw== 0000891092-97-000381.txt : 19971002 0000891092-97-000381.hdr.sgml : 19971002 ACCESSION NUMBER: 0000891092-97-000381 CONFORMED SUBMISSION TYPE: 8-A12B PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19971001 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: HEMISPHERX BIOPHARMA INC CENTRAL INDEX KEY: 0000946644 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 520845822 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-A12B SEC ACT: SEC FILE NUMBER: 001-13441 FILM NUMBER: 97689522 BUSINESS ADDRESS: STREET 1: 1617 JFK BLVD STREET 2: ONE PENN CENTER CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 2159880080 MAIL ADDRESS: STREET 1: 1617 JFK BLVD STREET 2: ONE PENN CENTER CITY: PHILADELPHIA STATE: PA ZIP: 19103 8-A12B 1 FORM 8-A FORM 8-A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 10549 FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Hemispherx Biopharma, Inc. (Exact name of registrant as specified in its charter) Delaware 52-0845822 (State of incorporation (I.R.S. Employer or organization) Identification No.) 1617 JFK Boulevard, 19103 Philadelphia, Pennsylvania (Zip Code) (Address of principal executive offices) Securities to be registered pursuant to Section 12(b) of the Act. Title of each class Name of each exchange on which to be so registered each class is to be registered Common Stock, $.001 Par Value American Stock Exchange Class A Redeemable Common Stock Purchase Warrants American Stock Exchange Item 1. Description of Registrant's Securities to be Registered. The securities to be registered pursuant to this Registration Statement under Section 12(b) of the Securities Act of 1933, as amended, are shares of the Registrant's Common Stock and Class A Redeemable Common Stock Purchase Warrants. Reference is hereby made to the description set forth under the caption "Description of Securities" contained in the Prospectus contained the Registrant's Registration Statement on Form S-1 (File No. 33-93314), as amended ("Registration Statement") as filed with the Securities and Exchange Commission and which is hereby incorporated by reference. Item 2. Exhibits 1. Amended and Restated Certificate of Incorporation of the Registrant, incorporated herein by reference to Exhibit 3.1 of the Registration Statement. 2. By-laws of the Registrant, as amended, incorporated herein by reference to Exhibit 3.2 of the Registration Statement. 3. Specimen Common Stock Certificate of the Registrant, incorporated herein by reference to Exhibit 4.1 of the Registration Statement. 4. Form of Class A Redeemable Warrant Certificate of the Registrant, incorporated herein by reference to Exhibit 4.2 of the Registration Statement. 5. Class A Redeemable Warrant Agreement of the Registrant, incorporated herein by reference to Exhibit 4.4 of the Registration Statement. The Registrant hereby incorporates by reference into this registration statement the description of its Common Stock and Class A Redeemable Common Stock Purchase Warrants included in any form of prospectus subsequently filed by the Registrant pursuant to Rule 424(b) under the Securities Act of 1933, as amended. 2 SIGNATURE Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized. HEMISPHERX BIOPHARMA, INC. Date: October 1, 1997 By:/s/ DR. WILLIAM A. CARTER ----------------------------------- Dr. William A. Carter, President 3 -----END PRIVACY-ENHANCED MESSAGE-----